BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 31977240)

  • 1. A Study of Factors Associated with the Development of Pseudoaldosteronism in Outpatients.
    Mantani N; Oka H; Watanabe T
    J Altern Complement Med; 2020 Apr; 26(4):329-334. PubMed ID: 31977240
    [No Abstract]   [Full Text] [Related]  

  • 2. Exploration for the real causative agents of licorice-induced pseudoaldosteronism.
    Makino T
    J Nat Med; 2021 Mar; 75(2):275-283. PubMed ID: 33481180
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of clinical factors associated with Kampo formula-induced pseudoaldosteronism based on self-reported information from the Japanese Adverse Drug Event Report database.
    Uneda K; Kawai Y; Kaneko A; Kayo T; Akiba S; Ishigami T; Yoshida-Komiya H; Suzuki M; Mitsuma T
    PLoS One; 2024; 19(1):e0296450. PubMed ID: 38165850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 3-Monoglucuronyl glycyrrhretinic acid is a possible marker compound related to licorice-induced pseudoaldosteronism.
    Makino T
    Biol Pharm Bull; 2014; 37(6):898-902. PubMed ID: 24882402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for pseudoaldosteronism with rhabdomyolysis caused by consumption of drugs containing licorice and differences between incidence of these conditions in Japan and other countries: case report and literature review.
    Yoshino T; Yanagawa T; Watanabe K
    J Altern Complement Med; 2014 Jun; 20(6):516-20. PubMed ID: 24620820
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of glycyrrhizin metabolites in humans and of a potential biomarker of liquorice-induced pseudoaldosteronism: a multi-centre cross-sectional study.
    Takahashi K; Yoshino T; Maki Y; Ishiuchi K; Namiki T; Ogawa-Ochiai K; Minamizawa K; Makino T; Nakamura T; Mimura M; Watanabe K
    Arch Toxicol; 2019 Nov; 93(11):3111-3119. PubMed ID: 31605160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk Factors for Pseudoaldosteronism with Yokukansan Use: Analysis Using the Japanese Adverse Drug Report (JADER) Database.
    Ishida T; Kawada K; Morisawa S; Jobu K; Morita Y; Miyamura M
    Biol Pharm Bull; 2020; 43(10):1570-1576. PubMed ID: 32999167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 18β-glycyrrhetyl-3-O-sulfate would be a causative agent of licorice-induced pseudoaldosteronism.
    Ishiuchi K; Morinaga O; Ohkita T; Tian C; Hirasawa A; Mitamura M; Maki Y; Kondo T; Yasujima T; Yuasa H; Minamizawa K; Namiki T; Makino T
    Sci Rep; 2019 Feb; 9(1):1587. PubMed ID: 30733510
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pseudoaldosteronism].
    Miyamori I
    Nihon Rinsho; 2012 Aug; 70 Suppl 6():720-4. PubMed ID: 23156604
    [No Abstract]   [Full Text] [Related]  

  • 10. Risk factors associated with pseudoaldosteronism in patients with chronic hepatitis: A retrospective cohort study.
    Komatsu A; Yoshino T; Suzuki T; Nakamura T; Kanai T; Watanabe K
    Basic Clin Pharmacol Toxicol; 2019 May; 124(5):607-614. PubMed ID: 30471199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3-Monoglucuronyl-glycyrrhretinic acid is a substrate of organic anion transporters expressed in tubular epithelial cells and plays important roles in licorice-induced pseudoaldosteronism by inhibiting 11β-hydroxysteroid dehydrogenase 2.
    Makino T; Okajima K; Uebayashi R; Ohtake N; Inoue K; Mizukami H
    J Pharmacol Exp Ther; 2012 Aug; 342(2):297-304. PubMed ID: 22543032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Licorice of 'shakuyaku kanzou tou' induced pseudoaldosteronism].
    Kanda H; Sakurai M; Arima K
    Hinyokika Kiyo; 2004 Mar; 50(3):215-7. PubMed ID: 15148778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Scientific Evaluation of Crude Drugs and Kampo Medicines Using the Eastern Blotting Method and Its Application to Biological Metabolic Studies].
    Morinaga O
    Yakugaku Zasshi; 2018; 138(6):743-750. PubMed ID: 29863039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics-based identification of pseudoaldosterogenic compounds originating from Glycyrrhiza uralensis roots (Gancao) after dosing LianhuaQingwen capsule.
    Lan XF; Olaleye OE; Lu JL; Yang W; Du FF; Yang JL; Cheng C; Shi YH; Wang FQ; Zeng XS; Tian NN; Liao PW; Yu X; Xu F; Li YF; Wang HT; Zhang NX; Jia WW; Li C
    Acta Pharmacol Sin; 2021 Dec; 42(12):2155-2172. PubMed ID: 33931765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Licorice-induced pseudoaldosteronism.
    Wash LK; Bernard JD
    Am J Hosp Pharm; 1975 Jan; 32(1):73-4. PubMed ID: 1124783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adverse Effects of Kampo Medicines.
    Shimada Y
    Intern Med; 2022 Jan; 61(1):29-35. PubMed ID: 33551404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural liquorice-induced pseudoaldosteronism causing severe hypokalaemia, hypertension and rhabdomyolysis.
    Angus L; Stranks J
    Intern Med J; 2020 Apr; 50(4):502-503. PubMed ID: 32270620
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical Risk Factors of Licorice-Induced Pseudoaldosteronism Based on Glycyrrhizin-Metabolite Concentrations: A Narrative Review.
    Yoshino T; Shimada S; Homma M; Makino T; Mimura M; Watanabe K
    Front Nutr; 2021; 8():719197. PubMed ID: 34604277
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Licorice-induced pseudoaldosteronism in a patient with a non-functioning adrenal tumor].
    Nobata S; Ohira T; Nagae H; Ushiyama T; Suzuki K; Fujita K
    Hinyokika Kiyo; 2001 Sep; 47(9):633-5. PubMed ID: 11692600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of pseudoaldosteronism induced by a mouth refresher containing licorice.
    Kageyama K; Watanobe H; Nishie M; Imamura K; Suda T
    Endocr J; 1997 Aug; 44(4):631-2. PubMed ID: 9447302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.